Myr (MYRG) Cash & Equivalents (2010 - 2026)

Myr (MYRG) has reported Cash & Equivalents for 17 consecutive years, with $137.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 500.59% year-over-year to $137.9 million in Q2 2026; TTM through Jun 2026 was $137.9 million, a 500.59% increase from a year earlier, with the FY2025 full-year figure at $150.2 million, up 4234.76% from the prior year.
• Cash & Equivalents was $137.9 million for Q2 2026 at Myr, down from $163.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $163.2 million in Q1 2026 and troughed at $1.9 million in Q2 2024.
• A 5-year average of $46.2 million and a median of $23.9 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents slumped 91.82% in 2024 and surged 4234.76% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $51.0 million in 2022, then tumbled by 51.22% to $24.9 million in 2023, then sank by 86.09% to $3.5 million in 2024, then surged by 4234.76% to $150.2 million in 2025, then fell by 8.18% to $137.9 million in 2026.
• The last three Cash & Equivalents figures came in at $137.9 million (Q2 2026), $163.2 million (Q1 2026), and $150.2 million (Q4 2025), per Business Quant data.